{
    "eid": "2-s2.0-85164865280",
    "title": "Bioactive Components of Bitter Melon (Momordica charantia L.) and Their Antidiabetic Response",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Agricultural and Biological Sciences (all)",
            "@code": "1100",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Engineering (all)",
            "@code": "2200",
            "@abbrev": "ENGI"
        }
    ],
    "keywords": [],
    "authors": [
        "Kishoree Krishna Kumaree",
        "Anchalee Prasansuklab"
    ],
    "citedby-count": 0,
    "ref-count": 96,
    "ref-list": [
        "Chemopreventive and anticarcinogenic effects of Momordica charantia extract",
        "Benefcial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat",
        "Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat",
        "Cucurbitanetype triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects",
        "Benefcial role of bitter melon supplementation in obesity and related complications in metabolic syndrome",
        "Effects of moderate-intensity exercise with Momordica charantia L. Consumption on serum reverse cholesterol transport elements and lipid profle in men with type 2 diabetes",
        "Phytochemical, proximate and mineral analyses of the leaves of Gossypium hirsutum L. And Momordica charantia L",
        "Hypoglycaemic activity of different extracts of various herbal plants",
        "Response of gut microbiota and infammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats",
        "Phenolic contents and antioxidant activity of some food and medicinal plants",
        "Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infltration as well as infammatory cytokine expression in adipose tissues",
        "Bitter melon (Momordica charantia): A review of effcacy and safety",
        "Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990\u20132000)",
        "Study on the antitumor and immune-stimulating activity of polysaccharide from Momordica charantia",
        "The termination of early pregnancy in the mouse by \u03b2-momorcharin",
        "In vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24",
        "Bitter gourd (Momordica charantia) extract activates peroxisome pro-liferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells",
        "Evaluation of acute and sub-chronic toxicity of bitter melon seed extract in Wistar rats",
        "Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus",
        "Structure determination, bitterness evaluation and hepatic gluconeogenesis inhibitory activity of triterpenoids from the Momordica charantia fruit",
        "Immunomodulatory activity and partial characterisation of polysaccharides from Momordica charantia",
        "Antioxidative effect of conjugated linolenic acid in diabetic and non-diabetic blood: An in vitro study",
        "Protection of Momordica charantia polysaccharide against intracerebral hemorrhage-induced brain injury through JNK3 signaling pathway",
        "Infammation as a link between obesity, metabolic syndrome and type 2 diabetes",
        "The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo",
        "Cucurbitane triterpenoids from the fruits of Momordica charantia improve insulin sensitivity and glucose homeostasis in streptozotocin\u2010induced diabetic mice",
        "Hypoglycemic principle of Momordica charantia seeds",
        "Binding energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)",
        "Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia",
        "Role of GLP-1 in the hypoglycemic effects of wild bitter gourd",
        "Hypoglycemic herbs and their action mechanisms",
        "Oxidative stress and infammation: What polyphenols can do for us?",
        "Isolation and characterization of potential food preservative peptide from Momordica charantia L",
        "Recent advances in Momordica charantia: Functional components and biological activities",
        "Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency",
        "Phytopharmacological properties of Ficus racemosa Linn-An overview",
        "Protein/polypeptide-k obtained from Momordica charantia",
        "Diabetes and medicinal plants-A review",
        "Effects of bittergourd (Momordica charantia) seed and glibenclamide in streptozotocin induced diabetes mellitus",
        "A characterized saponin-rich fraction of Momordica charantia shows antidiabetic activity in C57BLK/6 mice fed a high fat diet",
        "Hypoglycemic activity of polypeptide-p from a plant source",
        "Hypoglycemic effcacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus",
        "Hyperglycemic crises in adult patients with diabetes: A consensus statement from the American Diabetes Association",
        "Bitter gourd suppresses lipopolysaccharide-induced infammatory responses",
        "\u03b1-Eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd",
        "Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania",
        "Toxicity of oral agents used to treat diabetes",
        "The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia)",
        "Toxicity of Momordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes",
        "A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway",
        "Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor",
        "Gastro-resistant insulin receptor-binding peptide from momordica charantia improved the glucose tolerance in streptozotocin-induced diabetic mice via insulin receptor signaling pathway",
        "Note on a hypoglycaemic principle isolated from the fruits of Momordica charantia",
        "Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats",
        "Two new bidesmoside triterpenoid saponins from the seeds of Momordica charantia L",
        "Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats",
        "Momordica charantia reverses type II diabetes in rat",
        "Targeting Sirt1, AMPK, Nrf2, CK2 and soluble guanylate cyclase with nutraceuticals: A practical strategy for preserving bone mass",
        "Preparation of an antitumor and antivirus agent: Chemical modifcation of \u03b1-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol",
        "Low-grade infammation, diet composition and health: Current research evidence and its translation",
        "Effect of Momordica charantia on adenosine monophosphate-activated protein kinase in genetically type 2 diabetic mice muscle",
        "Anti-hyperglycemic activity of HPLC-fractionated Momordica charantia seed extract enriched in a novel napin-like protein in experimental diabetic rats and its validation with recombinant napin-like protein",
        "Ayurvedic polyherbal combination (PDBT) for prediabetes: A randomized double blind placebo controlled study",
        "\u03b1-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia",
        "Antidiabetic herbal drugs a review",
        "Momordica charantia L. Extract protects hippocampal neuronal cells against PAHs-induced neurotoxicity: Possible active constituents include stigmasterol and vitamin",
        "Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo",
        "New approach for extraction of charantin from Momordica charantia with pressurized liquid extraction",
        "Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy",
        "Antioxidant, total phenolic content and cytotoxicity evaluation of selected Malaysian plants",
        "Effects of Momordica charantia (karela/bittergourd) in type 2 diabetic patients taking allopathic drugs: A pilot study",
        "New insights into the bioactivity of cucurbitacins",
        "Bitter melon (Momordica charantia L) fruit decreased blood glucose level and improved lipid profle of streptozotocin induced hyperglycemia rats",
        "The effects of oral supplementation of bitter melon (Momordica charantia L.) leaves extract on the VEGF serum level in diabetic foot ulcers: Randomized controlled trial",
        "Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment",
        "Some observations on hypoglycaemic activity of Momordica charantia",
        "Global estimates of the prevalence of diabetes for 2010 and 2030",
        "Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats",
        "Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet",
        "Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-infammatory activities and in silico modeling approaches",
        "Effects of Momordica charantia (Bitter gourd) and Trigonella foenumgraecum (Fenugreek) supplements in type-2 diabetics taking allopathic drugs",
        "Anti-diabetic activity of polypeptide-K isolated from Momordica charantia: A retrospective study of 142 cases",
        "The triterpenoids of the bitter gourd (Momordica Charantia) and their pharmacological activities: A review",
        "Bitter melon (Momordica charantia L.) bioactive composition and health benefts: A review",
        "Tumor growth suppression by \u03b1-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation",
        "Antihyperglycemic effects of three extracts from Momordica charantia",
        "Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia",
        "Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L",
        "Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor \u03b3 activation",
        "Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice",
        "A mini-review of chemical and biological properties of polysaccharides from Momordica charantia",
        "Postprandial glucose levels are better associated with the risk factors for diabetes compared to fasting glucose and glycosylated hemoglobin (HbA1c) levels in elderly prediabetics: Benefcial effects of polyherbal supplements \u2013 A randomized, double-blind, placebo controlled trial",
        "PDX1, Neurogenin-3, and MAFA: Critical transcription regulators for beta cell development and regeneration"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}